What is the maximum recommended dose of midazolam (Benzodiazepine) for an adult and pediatric patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Recommended Dosage of Midazolam for Adults and Pediatric Patients

The maximum recommended dose of midazolam varies by indication, route of administration, and patient population, with intravenous doses generally not exceeding 6 mg for adults in procedural sedation and 5 μg/kg/min for pediatric patients in refractory status epilepticus. 1, 2

Adult Dosing

Intravenous Administration

  • Procedural Sedation:
    • Initial dose: 1-2 mg IV (0.03 mg/kg)
    • Additional doses: 1 mg every 2 minutes until adequate sedation
    • Maximum total dose: 6 mg typically not exceeded 1
    • Elderly (>60 years) or ASA III+ patients: Reduce dose by 20% or more 1

Intramuscular Administration

  • Preoperative Sedation:
    • Standard dose: 0.07-0.08 mg/kg IM (approximately 5 mg)
    • Maximum: No specific maximum stated, but dose should be reduced in elderly, COPD patients, and those on other CNS depressants 2

Continuous Infusion

  • Maintenance of Sedation:
    • Loading dose: 0.01-0.05 mg/kg
    • Infusion rate: 0.02-0.10 mg/kg/hr (1-7 mg/hr)
    • Higher rates may occasionally be required 2

Pediatric Dosing

Intravenous Administration

  • Procedural Sedation:
    • Ages 6 months-5 years: Initial 0.05-0.1 mg/kg, total up to 0.6 mg/kg 3
    • Ages 6-12 years: Initial 0.025-0.05 mg/kg, total up to 0.4 mg/kg 3
    • Note: Pediatric patients generally require higher mg/kg dosages than adults 2

Intramuscular Administration

  • Procedural Sedation:
    • Standard dose: 0.1-0.15 mg/kg
    • For anxious patients: Up to 0.5 mg/kg
    • Maximum: Total dose usually does not exceed 10 mg 2

Seizure Management

  • Intramuscular for Acute Seizures:

    • Dose: 0.2 mg/kg (maximum: 6 mg per dose)
    • May repeat every 10-15 minutes 1, 4
  • Intravenous for Refractory Status Epilepticus:

    • Loading dose: 0.15-0.20 mg/kg
    • Continuous infusion: Start at 1 μg/kg/min
    • Increase by 1 μg/kg/min every 15 minutes
    • Maximum infusion rate: 5 μg/kg/min 1, 4

Special Considerations

  1. Respiratory Monitoring:

    • Respiratory depression is the most serious adverse effect
    • Continuous monitoring of oxygen saturation is essential
    • Have resuscitation equipment immediately available 1, 4
  2. Dose Adjustments Required:

    • Elderly patients (>60 years): Reduce dose by ≥20%
    • Hepatic/renal impairment: Reduce dose
    • When combined with opioids: Reduce dose due to synergistic effects 1, 4, 2
  3. Administration Rate:

    • Administer IV doses slowly (over at least 2 minutes)
    • Allow 2-3 minutes between doses to evaluate effect 2
  4. Reversal Agent:

    • Flumazenil can reverse respiratory depression
    • Caution: May precipitate seizures in epileptic patients 1, 4

Clinical Pitfalls to Avoid

  • Rapid administration can cause severe respiratory depression and hypotension
  • Failure to reduce dose when combining with opioids or other CNS depressants
  • Inadequate monitoring of respiratory status, especially in the first 30 minutes after administration
  • Overlooking age-related sensitivity in elderly patients and very young children
  • Using standard adult dosing for pediatric patients (must calculate on mg/kg basis)

The dosing recommendations above represent maximum doses under optimal monitoring conditions. In clinical practice, using the lowest effective dose and careful titration is essential for patient safety.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Seizure Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.